 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Mechanisms of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance and Strategies to Overcome Resistance in Lung Adenocarcinoma |
| Yoon Soo Chang, Chang-Min Choi, Jae Cheol Lee |
|
Tuberc Respir Dis. 2016;79(4):248-256. Published online October 5, 2016 DOI: https://doi.org/10.4046/trd.2016.79.4.248 |
|
Mechanisms of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance and Strategies to Overcome Resistance in Lung Adenocarcinoma Tuberculosis and Respiratory Diseases. 2016;79(4):248  Resistance to epidermal growth factor receptor tyrosine kinase inhibitors in mutated non-small cell lung cancer: new avenues and strategies to overcome resistance memo - Magazine of European Medical Oncology. 2019;12(2):128-135 Fluorescence Imaging of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance in Non-Small Cell Lung Cancer Cancers. 2022;14(3):686 Overcoming Molecular Mechanisms of Resistance to First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Clinical Lung Cancer. 2012;13(4):267-279 Does the Addition of Vascular Endothelial Growth Factor Inhibitors to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Overcome T790M Acquired Resistance? Journal of Thoracic Oncology. 2011;6(2):404 Progress toward resistance mechanism to epidermal growth factor receptor tyrosine kinase inhibitor Open Life Sciences. 2016;11(1):427-431 Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancers Dependent on the Epidermal Growth Factor Receptor Pathway Clinical Lung Cancer. 2009;10(4):281-289 Resistance mechanisms causing first-line epidermal growth factor receptor-tyrosine kinase inhibitor treatment failure Annals of Oncology. 2017;28:x131 Resistance to anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKIs) in patients with lung cancer: Single mutations, compound mutations, and other mechanisms of drug resistance Therapeutic Strategies to Overcome ALK Resistance in Cancer. 2021;87-99 Synthetic epidermal growth factor receptor (EGFR)-mitochondria desired axles-based split green-fluorescent-protein (GFP) could screen for the signaling molecules that overcome the drug resistance to tyrosine kinase inhibitor (TKI) Research Ideas and Outcomes. 2016;2:e9551 |
